The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
WEZLANA ustekinumab 5 mg / 1.0 mL (130 mg/26 mL) solution for intravenous infusion injection vial (403014)
ARTG Name
WEZLANA ustekinumab 5 mg / 1.0 mL (130 mg/26 mL) solution for intravenous infusion injection vial
Product name
WEZLANA ustekinumab 5 mg / 1.0 mL(130 mg/26 mL) solution for intravenous infusion injection vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicine
Sponsor
Ingredients
Ustekinumab
Licence category
RE
Licence status
A
Summary